Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Certara2026 年 6 月 26 日

Announcement

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…

Danielle Pillsbury2026 年 6 月 23 日

Poster

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…

Certara2026 年 6 月 23 日

Poster

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…

Certara2026 年 6 月 23 日

Poster

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…

Certara2026 年 6 月 22 日

Poster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…

Certara2026 年 6 月 22 日

Poster

Machine Learning based drug renal clearance predictor development and application

A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…

Certara2026 年 6 月 22 日

Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…

Certara2026 年 6 月 18 日

Webinar

Building IND-Ready and Investor-Ready Development Programs

Certara2026 年 6 月 15 日

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

Certara2026 年 6 月 11 日

药物开发

Enhancing clinical trials with real-world evidence in pregnancy research

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Machine Learning based drug renal clearance predictor development and application

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Building IND-Ready and Investor-Ready Development Programs

2026 Simcyp Workshops

订阅时事通讯

快捷链接

解决方案

联系我们